Biomarkers Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Biotech companies at Biomarkers Europe 2026
Oct 13–14, 2026 Basel, Switzerland ~1k attendees Website
9 biotech companies are at Biomarkers Europe 2026 — 12 presentations on the program. Most represented: BioAge Labs (1 on the program), Monte Rosa Therapeutics (1 on the program), Step Pharma (1 on the program). 3 of them have their own page in this guide. As of Oct 8, 2026.
Topic
Top represented
Showing 1–9 of 9 organizations
| Organization | Biomarkers Europe 2026 Attendance |
|---|---|
BioAge Labs Richmond, CA | |
Clinical-stage biotech developing drugs for obesity and metabolic diseases based on the biology of aging. | Panel Tue Oct 13 12:40pm–1:30pm Application And Integration Of Proteomic Biomarkers In Precision Medicine Genomics, proteomics and multi-omicsBiomarker discovery & translation Talk Wed Oct 14 11:45am–12:10pm |
Monte Rosa Therapeutics Boston, MA | |
Develops molecular glue degrader drugs that direct the cell's protein disposal machinery against targets in oncology and immunology. | Talk Tue Oct 13 12:40pm–1:05pm Biomarker Modalities In Early Development Of Molecular Glue Degraders For Oncology And Immune-Mediated Diseases Biomarker discovery & translation Panel Tue Oct 13 1:05pm–1:30pm Translating Biomarkers From Discovery To Clinical Use Biomarker discovery & translation |
Step Pharma Saint-Genis-Pouilly, France | |
Clinical-stage biotech developing CTPS1 inhibitors, led by oral dencatistat, for lymphomas and solid tumours. | Panel Tue Oct 13 1:05pm–1:30pm Translating Biomarkers From Discovery To Clinical Use Biomarker discovery & translation Panel Wed Oct 14 1:00pm–1:30pm From Silos To Alliances – Rethinking Collaboration In Precision Medicine Drug–diagnostic commercialization & access |
Ablevia Vienna, Austria | |
Develops injectable compounds that selectively remove anti-drug and anti-vector antibodies so biologic and gene therapies can work as intended. | Talk Tue Oct 13 5:20pm–5:30pm Start Up Zone: ADAscape™: High-Resolution Epitope Profiling For Anti-Drug And Anti-Vector Antibodies Biomarker discovery & translation |
Engitix London, UK | |
Develops drugs for fibrotic diseases and solid tumours based on human extracellular matrix biology. | Panel Tue Oct 13 12:40pm–1:30pm Application And Integration Of Proteomic Biomarkers In Precision Medicine Genomics, proteomics and multi-omicsBiomarker discovery & translation |
FoRx Therapeutics Basel, Switzerland | |
Develops cancer drugs that target DNA replication stress, including PARG inhibitors. | Talk Tue Oct 13 5:10pm–5:35pm |
Healiva Lugano, Switzerland | |
Develops cell-based and enzymatic therapies for chronic wound care. | Panel Tue Oct 13 5:10pm–6:00pm AI-Powered Precision Medicine Multimodal & AI-enabled precision medicine |
Muna Therapeutics Copenhagen, Denmark | |
Develops disease-modifying drugs for neurodegenerative diseases such as Alzheimer's and Parkinson's. | Panel Wed Oct 14 1:00pm–1:30pm Biomarker Strategies In Neurodegenerative Therapeutics Biomarker discovery & translation |
Develops an Alzheimer's drug and a diagnostic biomarker based on its T14 peptide mechanism of neurodegeneration. | Panel Wed Oct 14 1:00pm–1:30pm Biomarker Strategies In Neurodegenerative Therapeutics Biomarker discovery & translation |
Instantly find 20 buyers from biotech companies
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse Biomarkers Europe 2026 by
Organization type
Topic
Everyone
Not affiliated with or endorsed by Biomarkers, CDx & Precision Medicine or its organizers. Submit a correction